Welcome to the international HTA database

Showing [24114 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Semaglutide 2 mg for type 2 diabetes
2023	National Institute for Health and Care Excellence (NICE)	Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal). NICE technology appraisal guidance 910
2023	National Institute for Health and Care Excellence (NICE)	Semaglutide for managing overweight and obesity. NICE technology appraisal guidance 875
2005	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2002	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2011	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Semi-implantable, middle ear hearing aids
2011	HAYES, Inc.	Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2013	HAYES, Inc.	SensiGene fetal RHD genotyping
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Sensimed triggerfish® for 24-hour monitoring of changes in intraocular pressure in glaucoma
2009	NIHR Health Technology Assessment programme	Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SensiumVitals® vital signs monitoring patch
2022	NIHR Health Technology Assessment programme	Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT
2000	HAYES, Inc.	Sensory integration therapy for children with learning disabilities
2004	HAYES, Inc.	Sensory integration therapy for children with learning disabilities or developmental delays
2014	HAYES, Inc.	Sensory integration therapy for non-autistic children
2003	Wessex Institute for Health Research and Development (WIHRD)	Sensory or auditory integration therapy for children with autistic spectrum disorders
2011	HAYES, Inc.	Sensory-based treatments for autism spectrum disorders
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ for sentinel lymph node localisation in breast cancer
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2006	Medical Services Advisory Committee (MSAC)	Sentinel lymph node biopsy in breast cancer
2013	NIHR Health Technology Assessment programme	Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2002	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Sentinel node biopsy (SNB) in breast cancer - progress report
2000	ECRI	Sentinel node biopsy for staging breast cancer
2001	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2005	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2019	National Institute for Health and Care Excellence (NICE)	Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. NICE medical technologies guidance 41
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Separate instrument sets for prevention of tumor seeding during tumor resection and flap surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for nonuterine abdominal adhesions
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of uterine adhesions
2016	NIHR Health Technology Assessment programme	Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation
2016	National Institute for Health and Care Excellence (NICE)	SepsiTest assay for rapidly identifying bloodstream bacteria and fungi. NICE diagnostics guidance 20
2012	HAYES, Inc.	Septin 9 (SEPT9) methylation analysis for colorectal cancer
2006	National Institute for Health and Care Excellence (NICE)	Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome. NICE interventional procedures guidance 199
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2012	Blue Cross Blue Shield Association (BCBS)	Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2005	Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ)	Sequential antibiotic treatment of pneumonia - primary research
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Seralite® for multiple myeloma and other B cell dyscrasias
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Serenity System® to treat tinnitus
2002	Blue Cross Blue Shield Association (BCBS)	Serial endpoint testing for the diagnosis and treatment of allergic disorders
2011	HAYES, Inc.	Serial Transverse Enteroplasty (STEP) for short bowel syndrome
2007	National Institute for Health and Care Excellence (NICE)	Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children. NICE interventional procedures guidance 232
2017	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with HPV vaccination
2019	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with influenza vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with oral cholera vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with yellow fever vaccination
2003	HAYES, Inc.	Serologic assays for the diagnosis and management of inflammatory bowel disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2002	Institute for Clinical Systems Improvement (ICSI)	Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2006	HAYES, Inc.	Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2012	Agency for Healthcare Research and Quality (AHRQ)	Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias
2003	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - systematic review, expert panel
2004	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - update of previous report
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2008	Quality Improvement Scotland (NHS QIS )	Service delivery organisation for acute low back pain
2024	NIHR Health Services and Delivery Research programme	Service design for children and young people with common mental health problems: literature review, service mapping and collective case study
2003	Adelaide Health Technology Assessment (AHTA)	Service improvement tools for the prevention, diagnosis and management of chronic diseases
2024	NIHR Health Services and Delivery Research programme	Service innovations for people with multiple long-term conditions: reflections of a rapid evaluation team
2015	NIHR Health Services and Delivery Research programme	Service user engagement and health service reconfiguration: a rapid evidence synthesis
2024	National Institute for Health and Care Excellence (NICE)	Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome. NICE highly specialised technologies guidance 31
2022	National Institute for Health and Care Excellence (NICE)	Setmelanotide for treating obesity caused by LEPR or POMC deficiency. NICE highly specialised technologies guidance 21
2000	Israel Center for Technology Assessment in Health Care (ICTAHC)	Setting priorities for the adoption of health technologies on a national level - the Israeli experience
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer in patients with end-stage renal disease: a systematic review and economic evaluation
2012	Institute for Clinical Evaluative Sciences (ICES)	Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2013	Health Quality Ontario (HQO)	Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Sex change surgery - expert panel. IPE-02/i
2004	HAYES, Inc.	Sex reassignment surgery and associated therapies for the treatment of gender identity disorder
2014	HAYES, Inc.	Sex reassignment surgery for the treatment of gender dysphoria
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sexual Assault Nurse Evaluation (SANE) rape crisis procedure: clinical effectiveness and guidelines
2010	Institute of Health Economics (IHE)	Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2013	Medical Services Advisory Committee (MSAC)	Sexual health medicine consultation items
2015	NIHR Public Health Research (PHR) programme	Sexual health promotion for young people delivered via digital media: a scoping review
2004	Agency for Healthcare Research and Quality (AHRQ)	Sexuality and reproductive health following spinal cord injury
2022	Agency for Care Effectiveness (ACE)	SGLT2 inhibitors for treating heart failure with reduced ejection fraction and chronic kidney disease
1997	VA Technology Assessment Program (VATAP)	Shared decision-making programs: a descriptive analysis of experience with shared decision-making programs in VA. A systematic review: assessing the effectiveness of shared decision-making programs for prostate care
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Shared governance for nursing assistants and other ancillary medical staff in the hospital setting
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Shared medical appointments (SMAs) for type 2 diabetes management
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Sheffield Support Snood for neurodegenerative conditions
2004	VA Technology Assessment Program (VATAP)	Shelf-life of stored sterilized materials: should VHA adopt expiration dating or event-related outdating?
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Shiftwork and health risks: possibilities for prevention
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2022	NIHR Health Technology Assessment programme	Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022	NIHR Health Technology Assessment programme	Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short- and long-term use of benzodiazepines in patients with generalized anxiety disorder: a review of guidelines
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting agents for procedural sedation and analgesia in Canadian emergency departments: a review of clinical outcomes and economic evaluation
2007	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2006	National Institute for Health and Care Excellence (NICE)	Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery. NICE interventional procedures guidance 177
2013	Health Quality Ontario (HQO)	Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review